Cargando…

Obesity enriches for tumor protective microbial metabolites and treatment refractory cells to confer therapy resistance in PDAC

Obesity causes chronic inflammation and changes in gut microbiome. However, how this contributes to poor survival and therapy resistance in patients with pancreatic cancer remain undetermined. Our current study shows that high fat diet-fed obese pancreatic tumor bearing mice do not respond to standa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kesh, Kousik, Mendez, Roberto, Mateo-Victoriano, Beatriz, Garrido, Vanessa T, Durden, Brittany, Gupta, Vineet K, Oliveras Reyes, Alfredo, Merchant, Nipun, Datta, Jashodeep, Banerjee, Santanu, Banerjee, Sulagna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275504/ https://www.ncbi.nlm.nih.gov/pubmed/35816618 http://dx.doi.org/10.1080/19490976.2022.2096328

Ejemplares similares

Therapy Resistance, Cancer Stem Cells and ECM in Cancer: The Matrix Reloaded
por: Kesh, Kousik, et al.
Publicado: (2020)

Stroma secreted IL6 selects for “stem-like” population and alters pancreatic tumor microenvironment by reprogramming metabolic pathways
por: Kesh, Kousik, et al.
Publicado: (2020)

Type 2 diabetes induced microbiome dysbiosis is associated with therapy resistance in pancreatic adenocarcinoma
por: Kesh, Kousik, et al.
Publicado: (2020)

Long non-coding RNA GAS5 acts as proliferation “brakes” in CD133+ cells responsible for tumor recurrence
por: Sharma, Nikita S., et al.
Publicado: (2019)

ER stress sensor, glucose regulatory protein 78 (GRP78) regulates redox status in pancreatic cancer thereby maintaining “stemness”
por: Dauer, Patricia, et al.
Publicado: (2019)

O-GlcNAc modification of Sox2 regulates self-renewal in pancreatic cancer by promoting its stability
por: Sharma, Nikita S, et al.
Publicado: (2019)

Deciphering high risk molecular alterations in gastrointestinal malignancy utilizing an extreme outlier strategy
por: Dosch, Austin R., et al.
Publicado: (2020)

Immune-related somatic mutation genes are enriched in PDACs with diabetes
por: Wang, Kaixuan, et al.
Publicado: (2019)

E-Cadherin: An Enigma in Pancreatic Diseases
por: Garrido, Vanessa T., et al.
Publicado: (2019)

Identification of scaffold/Matrix Attachment (S/MAR) like DNA element from the gastrointestinal protozoan parasite Giardia lamblia
por: Padmaja, Sushma S, et al.
Publicado: (2010)

Ras-p53 genomic cooperativity as a model to investigate mechanisms of innate immune regulation in gastrointestinal cancers
por: Dosch, Austin R., et al.
Publicado: (2021)

Scaling the immune incline in PDAC
por: Rojas, Luis A., et al.
Publicado: (2021)

Learning From Gender Disparity: Role of Estrogen Receptor Activation in Coping With Pancreatic Cancer
por: Gupta, Vineet K., et al.
Publicado: (2020)

Neutrophil-mediated fibroblast-tumor cell il-6/stat-3 signaling underlies the association between neutrophil-to-lymphocyte ratio dynamics and chemotherapy response in localized pancreatic cancer: A hybrid clinical-preclinical study
por: de Castro Silva, Iago, et al.
Publicado: (2022)

Transverse Space Charge Effect During Bunch Compression in PDAC1 and PDAC2 Compressor Ring
por: Franchetti, Giuliano
Publicado: (2000)

The role of survivin in the progression of pancreatic ductal adenocarcinoma (PDAC) and a novel survivin-targeted therapeutic for PDAC
por: Brown, Matthew, et al.
Publicado: (2020)

Mitochondrial Metabolism in PDAC: From Better Knowledge to New Targeting Strategies
por: Reyes-Castellanos, Gabriela, et al.
Publicado: (2020)

Autophagy is required for PDAC glutamine metabolism
por: Seo, Ju-Won, et al.
Publicado: (2016)

SIRT 1 Overexpression is Associated with Metastasis of Pancreatic Ductal Adenocarcinoma (PDAC) and Promotes Migration and Growth of PDAC Cells
por: Li, Siqin, et al.
Publicado: (2016)

Remodeling of Stromal Immune Microenvironment by Urolithin A Improves Survival with Immune Checkpoint Blockade in Pancreatic Cancer
por: Mehra, Siddharth, et al.
Publicado: (2023)

Accurate Estimation of Nucleic Acids by Amplification Efficiency Dependent PCR
por: Chatterjee, Nilanjana, et al.
Publicado: (2012)

Overexpression of Mesothelin in Pancreatic Ductal Adenocarcinoma (PDAC)
por: Le, Kai, et al.
Publicado: (2020)

The Microbiome in PDAC—Vantage Point for Future Therapies?
por: Pfisterer, Nina, et al.
Publicado: (2022)

International students in United States’ medical schools: does the medical community know they exist?
por: Datta, Jashodeep, et al.
Publicado: (2012)

Combatting PDAC with two tumor-targeting small RNAs
por: Kasinski, Andrea L.
Publicado: (2019)

Biological Hallmarks and New Therapeutic Approaches for the Treatment of PDAC
por: Digiacomo, Graziana, et al.
Publicado: (2021)

Cell Lineage Infidelity in PDAC Progression and Therapy Resistance
por: Malinova, Antonia, et al.
Publicado: (2021)

Loss of FGFR4 promotes the malignant phenotype of PDAC
por: D’Agosto, Sabrina, et al.
Publicado: (2022)

Targeting KRAS in PDAC: A New Way to Cure It?
por: He, Qianyu, et al.
Publicado: (2022)

Modifiable Pancreatic Ductal Adenocarcinoma (PDAC) Risk Factors
por: Michalak, Natalia, et al.
Publicado: (2023)

Fendiline Enhances the Cytotoxic Effects of Therapeutic Agents on PDAC Cells by Inhibiting Tumor-Promoting Signaling Events: A Potential Strategy to Combat PDAC
por: Alhothali, Marwa, et al.
Publicado: (2019)

Upregulated MicroRNA-483-3p is an Early Event in Pancreatic Ductal Adenocarcinoma (PDAC) and as a Powerful Liquid Biopsy Biomarker in PDAC
por: Shao, Huilin, et al.
Publicado: (2021)

PDAC-derived exosomes enrich the microenvironment in MDSCs in a SMAD4-dependent manner through a new calcium related axis
por: Basso, Daniela, et al.
Publicado: (2017)

Physical-Literacy-Enriched Physical Education: A Capabilities Perspective
por: Durden-Myers, Elizabeth, et al.
Publicado: (2023)

AHNAK2 is a potential prognostic biomarker in patients with PDAC
por: Lu, Di, et al.
Publicado: (2017)

Disruption of Broad Epigenetic Domains in PDAC Cells by HAT Inhibitors
por: Gerrard, Diana L., et al.
Publicado: (2019)

SMAD4 Y353C promotes the progression of PDAC
por: Wang, Zusen, et al.
Publicado: (2019)

Cohort Analysis of ADAM8 Expression in the PDAC Tumor Stroma
por: Jaworek, Christian, et al.
Publicado: (2021)

Exosomes in the Treatment of Pancreatic Cancer: A Moonshot to PDAC Treatment?
por: Papadakos, Stavros P., et al.
Publicado: (2022)

An integrated study to decipher immunosuppressive cellular communication in the PDAC environment
por: AVŞAR, Gülben, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r27om1qvq6avplj37dkd50hn1q